Biotechnology, Life Sciences, and Pharmaceutical Articles

Ventria Bioscience Cuts to The Chase!

May 6, 2021
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

March 10, 2021
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

January 5, 2021
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… Continue Reading →

Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership With The Chase Group

November 16, 2020
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually… Continue Reading →

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

July 10, 2020
The Chase Group, known for relationship building with proven success in life sciences executive search, was retained by Akcea Therapeutics, to identify and secure a… Continue Reading →

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

May 18, 2020
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson… Continue Reading →

Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs

March 26, 2020
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As… Continue Reading →

Eisai, Inc. Retains The Chase Group to Build US Medical Affairs Leadership Team

February 11, 2020
Eisai, Inc.’s partnership with Merck has proven to be successful with the FDA approval of the Keytruda and Lenvima Combination Treatment. With 13 indications for… Continue Reading →
Copyright © 1993-2024 The Chase Group. All Rights Reserved.